Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
The treatment of atopic eczema in adults
Carolyn Charman
Atopic eczema is a chronic inflammatory skin disease that predominantly occurs in childhood, with the majority (60%) of cases clearing spontaneously by adolescence. However, around 2% of adults are also affected by the disease, and in these patients the disease usually represents a lifelong chronic management problem. Most patients are managed in the community, where adults represent over a third of all atopic eczema cases.1 In this article, we discuss the current treatment options available for these patients, highlighting areas where evidence for treatments remains lacking.
Dermatology in practice
2000;
8
(4): 21–24
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
LEO Pharma’s Anzupgo cream granted EC approval in chronic hand eczema
UCB announces two-year data for Bimzelx in hidradenitis suppurativa
Sanofi/Regeneron’s Dupixent shows promise in phase 3 chronic spontaneous urticaria study
Merck announces ten-year data for anti-PD-1 therapy Keytruda in melanoma
Eli Lilly receives FDA approval for IL-13 inhibitor Ebglyss in atopic dermatitis
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy